Peginterferon α-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B

• Published in: Journal of viral hepatitis Vol. 10; no. 4; pp. 298 - 305
• Main Authors: Cooksley, W. G. E., Piratvisuth, T., Lee, S.-D., Mahachai, V., Chao, Y.-C., Tanwandee, T., Chutaputti, A., Chang, W. Yu, Zahm, F. E., Pluck, N.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Science Ltd 01.07.2003
• Subjects: alanine transaminase; chronic hepatitis B; hepatitis B e antigen; hepatitis B virus; interferon α-2a; viral DNA

Current therapies for chronic hepatitis B (CHB) have a number of limitations, and better treatment options are needed. Peginterferon α‐2a (40 kDa) is superior to conventional interferon α‐2a in the treatment of chronic hepatitis C. This is the first report on peginterferon α‐2a (40 kDa) in the treat...